|
BetaBart + unlabeled BetaBart Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1/2: 1
Top Sponsors
- Radiopharm Theranostics, Ltd1
Indications
- Head &Amp; Neck Squamous Cell Carcinoma (HNSCC)1
- Castration-Resistant Prostate Cancer (CRPC)1
- TNBC - Triple-Negative Breast Cancer1
- Small Cell Lung Cancer (SCLC)1
- NSCLC (Non-small Cell Lung Cancer)1
Dothan, Alabama1 trial
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Dothan Hematology & Oncology
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.